Skip to main content
OpenTrials
Completed

NCT Number: NCT01128283

Indicators of Inflammation and Coagulation in Sepsis

We will collect blood samples from patients with the diagnosis of sepsis and other ICU patients. We will describe the course of different mediator levels and organ injury markers and follow their progression throughout the course of the study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sepsis Infections Inflammation Pathologic Processes Pathological Conditions, Signs and Symptoms Systemic Inflammatory Response Syndrome

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

OU Medical Center

Oklahoma City, Oklahoma, 73104, United States

About this study

After informed consent is obtained 5 cc of blood is collected on the day of admission and on days 0, 1, 3, and 7 thereafter. Plasma is collected and frozen for the subsequent measurement of biomarkers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Admission to the ICU

Exclusion criteria

  • No blood draws scheduled
  • Hemoglobin level < 6,5 gm/dl

Treatment and study plan

Primary outcomes

  1. Death

    Time frame: 30 days

    Survival at 30 days

Sponsors and collaborators

Lead sponsor

University of Oklahoma

Other

Registry information

Official study title

Temporal Behavior of Coagulation Factors, Cytokines and Tissue Injury Markers in Sepsis

Important dates

Study start
2002
Primary completion
2014
Study completion
2014
First posted
May 21, 2010
Registry last updated
Sep 12, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.